Onyx Pharmaceuticals, Inc. (ONXX) Posts Wider than Expected Q2 Loss of 68c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St futures slide as rising oil, yields dampen mood
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
Tweet
Share
E-mailGet Alerts ONXX Hot Sheet
Price: $124.70 --0%
Financial Fact:
Revenue from collaboration agreement: 81.83M
Today's EPS Names:
PKE, BYRN, HELE, More
Financial Fact:
Revenue from collaboration agreement: 81.83M
Today's EPS Names:
PKE, BYRN, HELE, More
Join SI Premium – FREE
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) reported Q2 EPS of ($0.68), $0.02 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $72.7 million versus the consensus estimate of $72.07 million.
For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.
For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Helen of Troy (HELE) Tops Q2 EPS by 28c, Misses on Revenue; Offers FY27 Guidance
- Citi names 5 top chip picks ahead of Q3 earnings
- Crescent Energy to buy Devon Energy's Eagle Ford assets for $3.85B
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
